Zenas Biopharma (ZBIO) PT Lowered to $48 at Jefferies, 'we see clear path for approval (BLA submission planned in 2Q and MAA in 2H26')

Go back to Zenas Biopharma (ZBIO) PT Lowered to $48 at Jefferies, 'we see clear path for approval (BLA submission planned in 2Q and MAA in 2H26')
(NASDAQ: ZBIO) Delayed: 17.40 +0.27 (1.58%)
Previous Close $17.13    52 Week High $50.95 
Open $17.29    52 Week Low $18.06 
Day High $17.78    P/E N/A 
Day Low $17.05    EPS $0.00 
Volume 416,246